Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Endometrioid Endometrial Cancer”

97 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 97 results

Not applicableStudy completedNCT01208467
What this trial is testing

Prognostic Biomarkers in Patients With Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage I Uterine Corpus Cancer+3 more
Gynecologic Oncology Group 2,824
Testing effectiveness (Phase 2)Study completedNCT01935934
What this trial is testing

Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Endometrial Adenosquamous CarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mixed Cell Adenocarcinoma+7 more
National Cancer Institute (NCI) 102
Not applicableLooking for participantsNCT04291612
What this trial is testing

Observational Study of Women With Endometrial Cancer Who Receive the Standard Treatment for Their Disease

Who this might be right for
Endometrial CancerEndometrioid AdenocarcinomaEndometrial Cancer Stage I
Memorial Sloan Kettering Cancer Center 1,715
Testing effectiveness (Phase 2)Active Not RecruitingNCT00788671
What this trial is testing

Levonorgestrel-Releasing Intrauterine System in Treating Patients With Complex Atypical Hyperplasia or Grade I Endometrial Cancer

Who this might be right for
Atypical Endometrial HyperplasiaStage I Uterine Corpus Cancer AJCC v7Stage IA Uterine Corpus Cancer AJCC v7+2 more
M.D. Anderson Cancer Center 69
Testing effectiveness (Phase 2)Study completedNCT02684227
What this trial is testing

Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer

Who this might be right for
Recurrent Endometrial Endometrioid AdenocarcinomaRecurrent Uterine Corpus CarcinomaStage III Uterine Corpus Cancer AJCC v7+6 more
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07078838
What this trial is testing

Tirzepatide in Women With Obesity and Endometrial Intra-epithelial Neoplasia or Grade 1 Endometrial Cancer

Who this might be right for
Endometrial CancerEndometrial Intraepithelial NeoplasiaGrade 1 Endometrial Endometrioid Carcinoma
UNC Lineberger Comprehensive Cancer Center 40
Early research (Phase 1)Looking for participantsNCT05950464
What this trial is testing

Testing Different Amounts of the Combination of Drugs M1774 and ZEN-3694 for the Treatment of Recurrent Ovarian and Endometrial Cancer

Who this might be right for
Recurrent Endometrial CarcinomaRecurrent Endometrial Clear Cell AdenocarcinomaRecurrent Endometrial Endometrioid Adenocarcinoma+6 more
National Cancer Institute (NCI) 60
Testing effectiveness (Phase 2)Looking for participantsNCT06463028
What this trial is testing

Sapanisertib and Serabelisib (PIKTOR) With Paclitaxel and a Substudy With an Insulin-Suppressing Diet in Patients With Advanced/Recurrent Endometrial Cancer

Who this might be right for
Endometrial Cancer
Faeth Therapeutics 40
Testing effectiveness (Phase 2)Study completedNCT01210222
What this trial is testing

Trebananib in Treating Patients With Persistent or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+4 more
Gynecologic Oncology Group 35
Testing effectiveness (Phase 2)Study completedNCT03909152
What this trial is testing

Onapristone ER Alone Or In Combination With Anastrozole in Gynecologic Cancers That Respond to Progesterone

Who this might be right for
Granulosa Cell Ovarian CancerLow Grade Serous Ovarian/ Primary Peritoneal CancerEndometrioid Endometrial Cancer
Memorial Sloan Kettering Cancer Center 34
Large-scale testing (Phase 3)WithdrawnNCT05712941
What this trial is testing

Comparison of Letrozole With Lerociclib Versus Letrozole With Placebo Control in Patients With Advanced/Metastatic or Recurrent, Grade 1 or Grade 2 Endometrial Cancer

Who this might be right for
Endometrial Carcinoma
EQRx International, Inc.
Testing effectiveness (Phase 2)UnknownNCT00492778
What this trial is testing

Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer

Who this might be right for
Endometrial Endometrioid Adenocarcinoma, Variant With Squamous DifferentiationEndometrial Mucinous AdenocarcinomaEndometrial Squamous Cell Carcinoma+5 more
GOG Foundation 165
Testing effectiveness (Phase 2)Study completedNCT00087685
What this trial is testing

RAD001 in Recurrent Endometrial Cancer Patients

Who this might be right for
Endometrial Cancer
M.D. Anderson Cancer Center 35
Not applicableLooking for participantsNCT07062016
What this trial is testing

Molecular and ctDNA Characterization of High-Risk Endometrial Cancer

Who this might be right for
Endometrial CarcinomaEndometrial High Grade Endometrioid AdenocarcinomaStage II Endometrial Cancer+2 more
Mayo Clinic 100
Early research (Phase 1)Study completedNCT01440998
What this trial is testing

Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Clear Cell AdenocarcinomaEndometrial Mucinous Adenocarcinoma+13 more
National Cancer Institute (NCI) 18
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07139977
What this trial is testing

Study of EV for Recurrent Endometrial Carcinoma

Who this might be right for
Endometrial Cancer
William Bradley 12
Testing effectiveness (Phase 2)Looking for participantsNCT05231122
What this trial is testing

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

Who this might be right for
Ovarian Clear Cell AdenocarcinomaPlatinum-Sensitive Ovarian CarcinomaRecurrent Endometrial Serous Adenocarcinoma+12 more
Roswell Park Cancer Institute 80
Large-scale testing (Phase 3)Study completedNCT00006011
What this trial is testing

Comparison of Two Combination Chemotherapy Regimens Plus Radiation Therapy in Treating Patients With Stage III or Stage IV Endometrial Cancer

Who this might be right for
Endometrial AdenocarcinomaEndometrial Adenosquamous CarcinomaEndometrial Clear Cell Adenocarcinoma+3 more
Gynecologic Oncology Group 659
Testing effectiveness (Phase 2)Looking for participantsNCT07107334
What this trial is testing

Estimate Early Clinical Efficacy Signals of GLP-1 Agonist Administration in Conjunction With Levonorgestrel Intrauterine Device in Obese Patients With Endometrioid Intraepithelial Neoplasia

Who this might be right for
Endometrioid Endometrial Adenocarcinoma
University of Florida 20
Very early researchStudy completedNCT04049227
What this trial is testing

Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer

Who this might be right for
Endometrial Endometrioid Adenocarcinoma
Northwestern University 27
Load More Results